Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center

Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center

Abstract Background Tenecteplase (TNK) offers promising efficacy and safety data for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) and pharmacological advantages over alteplase (rt-PA), justifying its gradual adoption as primary thrombolytic agent. At our tertiary care center, we tra...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander Sekita, Gabriela Siedler, Jochen A. Sembill, Manuel Schmidt, Ludwig Singer, Bernd Kallmuenzer, Lena Mers, Anna Bogdanova, Stefan Schwab, Stefan T. Gerner
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Neurological Research and Practice
Subjects:
Ischemic stroke
Intravenous thrombolysis
Tenecteplase
Alteplase
Procedure times
Delayed time window
Online Access:https://doi.org/10.1186/s42466-025-00388-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s42466-025-00388-x

Similar Items